Cargando…
Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance
PURPOSE: The overexpression of ATP-binding cassette transporters (ABC transporters), mainly including permeability glycoproteins (P-gp), multidrug resistance (MDR)-related protein 1 (MRP1), and breast cancer resistance proteins (BCRP), is one of the main reasons for the development of MDR which dire...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112789/ https://www.ncbi.nlm.nih.gov/pubmed/30197538 http://dx.doi.org/10.2147/CMAR.S164766 |
_version_ | 1783350904466964480 |
---|---|
author | Meng, Fanqi Zou, Le Zhang, Tengyu Jiang, Lei Ding, Yao Yu, Peng Peng, Jie |
author_facet | Meng, Fanqi Zou, Le Zhang, Tengyu Jiang, Lei Ding, Yao Yu, Peng Peng, Jie |
author_sort | Meng, Fanqi |
collection | PubMed |
description | PURPOSE: The overexpression of ATP-binding cassette transporters (ABC transporters), mainly including permeability glycoproteins (P-gp), multidrug resistance (MDR)-related protein 1 (MRP1), and breast cancer resistance proteins (BCRP), is one of the main reasons for the development of MDR which directly leads to chemotherapy failure. However, most of the currently used detection methods in MDR-related studies are qualitative or semiquantitative, but not quantitative. As a result, the measurement criteria of different experiments are not unified. Moreover, there are many contradictory results of the studies of the induction effect of drugs on ABC transporters. So, it is necessary to establish a quantitative assay for the quantification of P-gp, MRP1, and BCRP to study the mechanism of drug resistance. METHODS: In this paper, a novel and advanced liquid chromatography/mass spectrometry (MS)/MS-based targeted proteomics method for the quantification of P-gp, MRP1, and BCRP was developed and validated. Then, the cell lines MCF-7, HepG-2, and SMMC-7721 were, respectively, induced by different concentrations of doxorubicin (adriamycin [ADM]), mitoxantrone (MX), and methotrexate (MTX), to establish resistance cell lines. The method established was used to quantify the expression of P-gp, MRP1, and BCRP. RESULTS: The result showed that the induction effects of drugs on protein were relatively stable and selective. ADM, MX, and MTX could induce overexpression of P-gp, MRP1, and BCRP. And, the induction effect of different drugs on proteins was selective. The pattern of overexpression of ABC transporters in the three types of resistance cell lines was different. CONCLUSION: During the development of drug resistance, the cell type and patch, but not drug type, were the most important determinant factors of the overexpression level of ABC transporters in resistance cell lines. This study provides a good foundation for understanding the development of drug resistance in cell lines and can be used to explain the contradictory results in other published studies as described above. |
format | Online Article Text |
id | pubmed-6112789 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-61127892018-09-07 Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance Meng, Fanqi Zou, Le Zhang, Tengyu Jiang, Lei Ding, Yao Yu, Peng Peng, Jie Cancer Manag Res Original Research PURPOSE: The overexpression of ATP-binding cassette transporters (ABC transporters), mainly including permeability glycoproteins (P-gp), multidrug resistance (MDR)-related protein 1 (MRP1), and breast cancer resistance proteins (BCRP), is one of the main reasons for the development of MDR which directly leads to chemotherapy failure. However, most of the currently used detection methods in MDR-related studies are qualitative or semiquantitative, but not quantitative. As a result, the measurement criteria of different experiments are not unified. Moreover, there are many contradictory results of the studies of the induction effect of drugs on ABC transporters. So, it is necessary to establish a quantitative assay for the quantification of P-gp, MRP1, and BCRP to study the mechanism of drug resistance. METHODS: In this paper, a novel and advanced liquid chromatography/mass spectrometry (MS)/MS-based targeted proteomics method for the quantification of P-gp, MRP1, and BCRP was developed and validated. Then, the cell lines MCF-7, HepG-2, and SMMC-7721 were, respectively, induced by different concentrations of doxorubicin (adriamycin [ADM]), mitoxantrone (MX), and methotrexate (MTX), to establish resistance cell lines. The method established was used to quantify the expression of P-gp, MRP1, and BCRP. RESULTS: The result showed that the induction effects of drugs on protein were relatively stable and selective. ADM, MX, and MTX could induce overexpression of P-gp, MRP1, and BCRP. And, the induction effect of different drugs on proteins was selective. The pattern of overexpression of ABC transporters in the three types of resistance cell lines was different. CONCLUSION: During the development of drug resistance, the cell type and patch, but not drug type, were the most important determinant factors of the overexpression level of ABC transporters in resistance cell lines. This study provides a good foundation for understanding the development of drug resistance in cell lines and can be used to explain the contradictory results in other published studies as described above. Dove Medical Press 2018-08-23 /pmc/articles/PMC6112789/ /pubmed/30197538 http://dx.doi.org/10.2147/CMAR.S164766 Text en © 2018 Meng et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Meng, Fanqi Zou, Le Zhang, Tengyu Jiang, Lei Ding, Yao Yu, Peng Peng, Jie Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance |
title | Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance |
title_full | Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance |
title_fullStr | Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance |
title_full_unstemmed | Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance |
title_short | Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance |
title_sort | using lc–ms/ms-based targeted proteomics to monitor the pattern of abc transporters expression in the development of drug resistance |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112789/ https://www.ncbi.nlm.nih.gov/pubmed/30197538 http://dx.doi.org/10.2147/CMAR.S164766 |
work_keys_str_mv | AT mengfanqi usinglcmsmsbasedtargetedproteomicstomonitorthepatternofabctransportersexpressioninthedevelopmentofdrugresistance AT zoule usinglcmsmsbasedtargetedproteomicstomonitorthepatternofabctransportersexpressioninthedevelopmentofdrugresistance AT zhangtengyu usinglcmsmsbasedtargetedproteomicstomonitorthepatternofabctransportersexpressioninthedevelopmentofdrugresistance AT jianglei usinglcmsmsbasedtargetedproteomicstomonitorthepatternofabctransportersexpressioninthedevelopmentofdrugresistance AT dingyao usinglcmsmsbasedtargetedproteomicstomonitorthepatternofabctransportersexpressioninthedevelopmentofdrugresistance AT yupeng usinglcmsmsbasedtargetedproteomicstomonitorthepatternofabctransportersexpressioninthedevelopmentofdrugresistance AT pengjie usinglcmsmsbasedtargetedproteomicstomonitorthepatternofabctransportersexpressioninthedevelopmentofdrugresistance |